ImmunologyJan 17, 2024|6 min readBy Alejandra Manjarrez, PhDSweetening the fight against cancer and autoimmune diseasesImmunologist Gabriel Rabinovich leverages his 30 years of experience studying sugar-binding proteins, galectins, for developing novel therapies.
Cancer ResearchAug 17, 2022|2 min readBy Lauren DrakeA universal drug target for ovarian cancerThe discovery of a blood vessel-promoting protein interaction found in all ovarian tumors may lead to a new druggable target for ovarian cancers.